CU Cancer Center member Theresa Medina, MD, highlights 5-year follow-up results from the C-144-01 trial showing durable responses and long-term survival benefit with lifileucel in advanced melanoma.
CU Anschutz
Anschutz Cancer Pavilion
1665 North Aurora Court
2004
Aurora, CO 80045